Dornier MedTech Announces Presentation of Positive Clinical Data at European Society of Sexual Medicine Congress 2019

Ljubljana, Slovenia, 13 February 2019 Dornier MedTech (Dornier), pioneer in creating extracorporeal shockwave technology for urological and orthopedic indications, today announced the presentation of new data from two clinical studies on low-intensity shockwaves (LiST) as a treatment for Erectile Dysfunction (ED) at the 21st Congress of the European Society of Sexual Medicine taking place in Read More…

We’re Recognizing ESWL Application Specialists Around the World – Win a Trip to Munich!

In commemoration of the very first Extracorporeal Shockwave Lithotripsy (ESWL) procedure performed on 7 February 1980, Dornier MedTech (Dornier) has announced a global competition to honour ESWL Application Specialists around the world. Many people have heard of the urologist, or even the nurse – but few know or understand the important role of ESWL Application Read More…

First patient in joint ESWT trial with NUH for Chronic Pelvis Pain Syndrome (CPPS) shares his story

First patient in joint ESWT trial with NUH for Chronic Pelvis Pain Syndrome (CPPS) shares his story Using the Dornier Aries 2, NUH has begun conducting clinical trials to use shock wave therapy as a modality to treat patients with chronic pelvis pain syndrome (CPPS). TODAYOnline reports that the first patient to undergo the treatment, Read More…

Aries/Aries 2 2018 Research Highlights

2018 has been a busy and productive year for Dornier MedTech GmbH. As a global market leader in urological disease treatment, we continue to innovate and advance medical technology in the treatment landscape of urology and are committed to establishing a growing body of clinical evidence to build on our clinical leadership. We explore exciting Read More…

Dornier MedTech’s New Urological Laser for Stone Lithotripsy Wins German Design Award

Dornier MedTech’s New Urological Laser for Stone Lithotripsy Wins German Design Award Dornier MedTech, a global leader in innovative kidney stone management and wholly owned subsidiary of Accuron MedTech Group (Accuron MedTech), today announced that its new urological laser for stone lithotripsy, Dornier Medilas H Solvo 35, was awarded the German Design Award 2019 for Read More…

Dornier MedTech Initiates New Clinical Study Investigating Dornier ARIES as a Treatment for MTrP-associated CPPS

Dornier MedTech Initiates New Clinical Study Investigating Dornier ARIES as a Treatment for MTrP-associated CPPS Dornier MedTech, a global leader in urology, today announced the initiation of a new clinical study to determine the safety and efficacy of low-intensity shockwave therapy (Li-SWT) to alleviate symptoms of Myofascial Trigger Point (MTrP)-associated Chronic Pelvic Pain Syndrome (CPPS). Read More…

Dornier MedTech Collaborator Awarded for Poster on Low Intensity Shockwave and Erectile Dysfunction

Landmark study indicates for the first time that LiST can be safely administered via Dornier’s ARIES 2 up to three times a week for the treatment of Erectile Dysfunction Dornier MedTech (Dornier), a global leader in urology and wholly owned subsidiary of Accuron MedTech Group (Accuron MedTech), today announced that its collaborating research team was Read More…

Corporate Sustainability At Dornier MedTech

Dornier MedTech is a medical device company focused on providing leading technology and improving life by delivering products and solutions to physicians, healthcare providers and research groups involved in urological care. Sustainability ensures safety, efficiency, and responsibility in a manner that protects Dornier employees, communities, shareholders, and the environment, now and in the future. Dornier Read More…

Advanced Kidney Stone Treatment Lithotripter Arrives In Japan

Dornier MedTech Brings the Most Advanced Kidney Stone Treatment Lithotripter—Dornier Delta® III—to Japan     Dornier MedTech, a global leader in innovative kidney stone management, has received PMDA (Pharmaceuticals and Medical Devices Agency) regulatory approval to market the Delta® III in Japan. This is the latest generation of the world’s best-selling and most clinically cited Read More…

New Laser Portfolio and Most Powerful Urological Laser

PRESS RELEASE   Dornier MedTech Introduces New Laser Portfolio and Most Powerful Urological Laser for Stone Lithotripsy in Singapore   Singapore, 12 July 2018 – Dornier MedTech (Dornier), a global leader in innovative kidney stone management, today announced the introduction in Singapore a new laser portfolio comprising of Dornier Medilas® H Solvo® 35 and Dornier Read More…

Poster Presentation At Asia Pacific Urofair 2018

PRESS RELEASE   Dornier MedTech Announces Poster Presentation At The Asia Pacific Urofair 2018 In Singapore Singapore, 12 July 2018 – Dornier MedTech, a global leader in innovative kidney stone management, today announced that it will be presenting at the annual Asia Pacific Urofair 2018 taking place at Grand Hyatt Singapore on 12 – 14 Read More…

  • XVII Congress of Russian Urological Society and Russian-Chinese Urology Forum

    November 8, 2018 - March 10, 2019

    Jekaterinburg

    Jekaterinburg, Russia

  • 21st Congress of the European Society for Sexual Medicine (ESSM)

    February 14, 2019 - February 19, 2019

    Ljubljana

    Ljubljana, Slovenia

  • Northwest Congress of Specialists in ESWL

    March 1, 2019

    St. Petersburg

    St. Petersburg, Russia

  • EAU 2019

    March 15, 2019 - March 19, 2019

    EAU 2019

    Barcelona, Spain